Analysis of outcomes after radical prostatectomy in patients eligible for active surveillance (PRIAS). (Q53128113)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Analysis of outcomes after radical prostatectomy in patients eligible for active surveillance (PRIAS) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Guillaume Ploussard

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Alexandre de la Taille

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Yves Allory

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Dimitri Vordos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Andras Hoznek

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Claude Clément Abbou

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Laurent Salomon

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

publication date

21 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

53-59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Active surveillance for prostate cancer: progress and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Pathological outcomes of candidates for active surveillance of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

The contemporary concept of significant versus insignificant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Active surveillance program for prostate cancer: an update of the Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Disease insight and treatment perception of men on active surveillance for early prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Pathologic outcomes of candidates for active surveillance undergoing radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Treatment outcomes of radical prostatectomy in potential candidates for 3 published active surveillance protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Age-adjusted validation of the most stringent criteria for active surveillance in low-risk prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

The role of biopsy core number in selecting prostate cancer patients for active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Biochemical Recurrence Following Robot-Assisted Radical Prostatectomy: Analysis of 1384 Patients with a Median 5-year Follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Careful Selection and Close Monitoring of Low-Risk Prostate Cancer Patients on Active Surveillance Minimizes the Need for Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Percent tumor involvement and risk of biochemical progression after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

Screen detected, low volume prostate cancer: the case for active treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11276.X

10.1111/J.1464-410X.2012.11276.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22726582%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference